Cibus (NASDAQ:CBUS) Shares Up 1.3% – Still a Buy?

by · The Cerbat Gem

Cibus, Inc. (NASDAQ:CBUS – Get Free Report) shares shot up 1.3% during mid-day trading on Tuesday . The stock traded as high as $1.6417 and last traded at $1.61. 70,891 shares changed hands during trading, a decline of 41% from the average daily volume of 121,012 shares. The stock had previously closed at $1.59.

Analyst Ratings Changes

Several analysts have weighed in on CBUS shares. Weiss Ratings lowered shares of Cibus from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, June 29th. Wall Street Zen raised shares of Cibus from a “sell” rating to a “hold” rating in a report on Saturday, July 25th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Cibus has a consensus rating of “Hold” and an average price target of $9.00.

Read Our Latest Stock Analysis on CBUS

Cibus Stock Performance

The firm has a market cap of $121.14 million, a P/E ratio of -0.96 and a beta of 1.59. The firm has a fifty day moving average of $1.77 and a 200-day moving average of $1.89.

Cibus (NASDAQ:CBUS – Get Free Report) last issued its earnings results on Thursday, August 13th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.10). Cibus had a negative return on equity of 287.03% and a negative net margin of 2,258.89%.The company had revenue of $0.99 million during the quarter, compared to analyst estimates of $1.70 million. Equities research analysts expect that Cibus, Inc. will post -1.13 earnings per share for the current year.

Institutional Trading of Cibus

Several hedge funds have recently bought and sold shares of the company. PACK Private Wealth LLC bought a new position in Cibus in the 4th quarter worth about $27,000. Dimensional Fund Advisors LP bought a new stake in shares of Cibus during the first quarter valued at approximately $33,000. Qube Research & Technologies Ltd bought a new stake in shares of Cibus during the second quarter valued at approximately $39,000. Rockland Trust Co. acquired a new position in shares of Cibus during the second quarter worth approximately $41,000. Finally, Squarepoint Ops LLC bought a new position in Cibus in the 3rd quarter worth approximately $62,000. 33.81% of the stock is currently owned by institutional investors.

About Cibus

(Get Free Report)

Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company’s platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.

The company’s core business centers on trait development services and licensing partnerships.

Further Reading